Biomedical investment and business development chatter
amgen
Gilead Now #2 in Market Cap
Hat tip to seekingalpha
As far as market cap is concerned, Gilead (GILD) at least
fleetingly topped Amgen (AMGN) as the world’s second highest valued
biotech company. Amgen has taken some hits recently over their anemia
drug franchise and yesterday were overtaken in market capitalization
by a company with a third their revenue.
I made a long Amgen call nearly a [...]
Top Biopharma Deals Q1 ‘08
It’s a just a quarter of the way into 2008 and it is clear the both large
biotech and pharma have holes to fill in thier pipeline. Six deals have
already been inked that total over a half a billion bio-dollars each.
Below are 4 of the top deals thus far:
Genzyme/Isis ($1,900M) - Genzyme paid Isis $175M in
cash [...]
© 2008 Pharmababble. 
Recent Comments